Skycraper Clinical Research Solutions Private Limited - Company Profile

It is a research & development private limited company based in Mehsana, Gujarat, India, established in 2017.

2017 Mehsana, Gujarat, India Active

Last Updated: January 06, 2026

About Skycraper Clinical Research Solutions Private Limited

Skycraper Clinical Research Solutions Private Limited, a active private limited company, was established on 24 March 2017 in Mehsana, Gujarat, India. Engaging in science research within the research & development sector, it holds CIN: U73100GJ2017PTC096490. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.49 M and a paid-up capital of ₹60.00 K .

It upholds a compliant status. Its leadership includes Chintan Nareshchandra Sheth (Director), Naynaben Ashvinbhai Vyas (Director). Past directors included Vishvas Nareshchandra Solanki, Poojaben Himatlal Parmar, Naynaben Ashvinbhai Vyas. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 34 /, Amrutpark Society, Visnagar, Link Road,, Mehsana, Gujarat, 384001.

Company Details

CIN/LLPIN
U73100GJ2017PTC096490
Registration Number
096490
Incorporation Date
24 March 2017
Authorized Capital
₹0.49 M
Paid-Up Capital
₹60.00 K
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.49 M as on 06-01-2026
Paid Up Capital ₹ 60.00 K as on 06-01-2026
Company Age 8 Year, 10 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** -39.94% (FY 2020)
Profit Growth **** 158.14% (FY 2020)
Ebitda **** 203.59% (FY 2020)
Net Worth 55.05% (FY 2020)
Total Assets **** 111.62% (FY 2020)

Comprehensive Company Insights

Explore comprehensive insights into Skycraper Clinical Research Solutions Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Skycraper Clinical Research Solutions Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Chintan Nareshchandra Sheth	Director	24 Mar 2017	Current
Naynaben Ashvinbhai Vyas	Director	05 Oct 2021	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	21 May 2019	Past
Pramod Abcsdd	Additional Director	18 Dec 2020	Past
Pramod Abcsdd	Additional Director	29 Sep 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Skycraper Clinical Research Solutions.

Skycraper Clinical Research Solutions Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 39.94% decrease. The company also saw a substantial improvement in profitability, with a 158.14% increase in profit. The company's net worth Soared by an impressive increase of 55.05%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-39.94%

*******

Revenue from Operations

*******

-40.34%

*******

Total Assets

*******

111.62%

*******

Profit or Loss

*******

158.14%

*******

Net Worth

*******

55.05%

*******

EBITDA

*******

203.59%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Skycraper Clinical Research Solutions?

Unlock access to Skycraper Clinical Research Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Skycraper Clinical Research Solutions?

Unlock and access historical data on people associated with Skycraper Clinical Research Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Skycraper Clinical Research Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skycraper Clinical Research Solutions's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Skycraper Clinical Research Solutions

Recent Activity within the Organization

Annual General Meeting

Skycraper Clinical Research Solutions Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Balance Sheet

The activity Skycraper Clinical Research Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
31 Mar 2025
Director Appointment

Naynaben Ashvinbhai Vyas was appointed as a Director was appointed as a Director on 05 Oct 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.
05 Oct 2021
Director Appointment

Progress on Chintan Nareshchandra Sheth was appointed as a Director was appointed as a Director on 24 Mar 2017 & has been associated with this company since 8 years 10 months . was documented.
24 Mar 2017
Company Incorporation

The activity Skycraper Clinical Research Solutions Private Limited was registered on 24 Mar 2017 with Roc Ahmedabad & aged 8 years 10 months as per MCA records. was completed.
24 Mar 2017

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Skycraper Clinical Research Solutions Private Limited?

The CIN of Skycraper Clinical Research Solutions Private Limited is U73100GJ2017PTC096490.

Where is Skycraper Clinical Research Solutions Private Limited headquartered?

Skycraper Clinical Research Solutions Private Limited is headquartered at 34 /, Amrutpark Society, Visnagar, Link Road,, Mehsana, Gujarat, 384001.

When was Skycraper Clinical Research Solutions Private Limited incorporated?

Skycraper Clinical Research Solutions Private Limited was incorporated on 24 March 2017.

Who are the current directors of Skycraper Clinical Research Solutions Private Limited?

The current directors of Skycraper Clinical Research Solutions Private Limited are

What is the primary industry of Skycraper Clinical Research Solutions Private Limited?

The primary industry of Skycraper Clinical Research Solutions Private Limited is Research & Development.

Is Skycraper Clinical Research Solutions Private Limited a listed company?

Skycraper Clinical Research Solutions Private Limited is unlisted.

What is the capital structure of Skycraper Clinical Research Solutions Private Limited?

The authorized capital of Skycraper Clinical Research Solutions Private Limited is ₹0.49 M, and the paid-up capital is ₹60.00 K .

What is the compliance status of Skycraper Clinical Research Solutions Private Limited?

The compliance status of Skycraper Clinical Research Solutions Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available